Similar Papers

Paper Title
Journal
Date
Author
Direct Oral Anticoagulant Concentrations in Obese and High Body Weight Patients: A Cohort Study.
Zahra Mahir ... Alexander T Cohen
Thrombosis and Haemostasis | VOL. 121
Zahra Mahir, et. al.Zahra Mahir ... Alexander T Cohen
30 Aug 2020
Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
Floris T.M Bosch ... Pieter W Kamphuisen
Thrombosis Research | VOL. 205
Floris T.M Bosch, et. al.Floris T.M Bosch ... Pieter W Kamphuisen
14 Jul 2021
Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery
M.W.M Schellings ... D Van De Kerkhof
Thrombosis Research | VOL. 139
M.W.M Schellings, et. al.M.W.M Schellings ... D Van De Kerkhof
18 Jan 2016
71 Safety of the use of direct oral anticoagulants (DOACS) in morbidly obese patients with non-valvular atrial fibrillation (NVAF) undergoing elective direct-current cardioversion (DCCV)
Siddhartha Mohan ... Ashwin Roy
-
Siddhartha Mohan, et. al.Siddhartha Mohan ... Ashwin Roy
01 Jul 2020
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Metastatic melanoma presenting with leucoerythroblastic blood film.
Carlo Zaninetti ... Adrian Schwarzer
British journal of haematology | VOL. -
Carlo Zaninetti, et. al.Carlo Zaninetti ... Adrian Schwarzer
15 Jan 2025
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib
Andrea Ceccardi ... Gabriele Zoppoli
British Journal of Haematology | VOL. -
Andrea Ceccardi, et. al.Andrea Ceccardi ... Gabriele Zoppoli
15 Jan 2025
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.
Jose R Álamo ... Marina Díaz‐Beyá
British journal of haematology | VOL. -
Jose R Álamo, et. al.Jose R Álamo ... Marina Díaz‐Beyá
13 Jan 2025
The dosage of ropeginterferon in polycythaemia vera: Balancing efficacy, safety and pharmacoeconomics across risk categories.
Tiziano Barbui ... Alessandro M Vannucchi
British journal of haematology | VOL. -
Tiziano Barbui, et. al.Tiziano Barbui ... Alessandro M Vannucchi
12 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.